AACR-Ocular Melanoma Foundation Career Development Award
Funding Amount
$150,000
Deadline
Deadline not published
Grant Type
Foundation
Deadline history & next window
- Cycle
- Annual
- Tracked since
- April 2026
Source: the cycle recorded on this listing. Confirm dates with the funder.
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Other requirements
- Postdoctoral or clinical research fellows
- Conducting ocular melanoma research
- Affiliated with research institutions
Overview
Funder: Ocular Melanoma Foundation in partnership with the American Association for Cancer Research (AACR)
Focus Area: Research on novel therapies and treatment approaches for uveal melanoma, particularly metastatic disease
Description
This is an annual peer-reviewed research award supporting postdoctoral or clinical research fellows conducting ocular melanoma research. The award encourages both promising and established researchers to establish and continue successful careers in ophthalmology, ocular oncology, melanoma biology, or similar fields.
Funding Focus
- Novel therapeutic approaches for metastatic uveal melanoma
- Clinical trial development
- Translational research
- Immunotherapy and combination therapies
- Mechanisms of treatment response and resistance
Recent Recipients
- 2022: Dr. Khan (Columbia University) - investigating BET and MEK inhibition in metastatic uveal melanoma
- 2021: Dr. Bagge (Sahlgrenska University Hospital, Sweden) - Phase I clinical trial on isolated hepatic perfusion with immunotherapy
- 2018: Dr. Skalet (Oregon Health and Science University) - circulating hybrid cells as prognostic biomarkers
Eligibility
- Postdoctoral or clinical research fellows
- Conducting ocular melanoma research
- Affiliated with research institutions
What Ocular Melanoma Foundation actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 4
- Total given
- $50K
- Median grant
- $10K
- Range
- $10K–$20K
- By dollars: California 40%, Pennsylvania 20%, District of Columbia 20%. Top recipient cities: Stanford, CA; Philadelphia, PA; Washington, DC.
Example grants
Stanford Health Care · Stanford, CA
Research
$20K
Thomas Jefferson University and Jefferson Health · Philadelphia, PA
Research
$10K
Melanoma Research Foundation · Washington, DC
Research
$10K
Duke Eye Center · Durham, NC
Research
$10K
Focus Areas & Funding Uses
Fields of Work
- Cancer
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $300,000
Deadline
November 10, 2026
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $150,000
Deadline
November 10, 2026
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
September 10, 2027
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $350,000
Deadline
November 6, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
National Institutes of Health
Amount
Up to $200,000
Deadline
November 17, 2026
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
National Institutes of Health
Amount
$3,400,000 total
Deadline
November 23, 2026
Ready to apply for AACR-Ocular Melanoma Foundation Career Development Award?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found AACR-Ocular Melanoma Foundation Career Development Award. Now let's win it.